Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Practice Point
  • Published:

Antipsychotics in patients with Alzheimer's disease—what is their clinical value?

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

References

  1. Ballard C and Howard R (2006) Neuroleptic drugs in dementia: benefits and harm. Nat Rev Neurosci 7: 492–500

    Article  CAS  Google Scholar 

  2. Schneider LS et al. (2005) Risk of death with atypical antipsychotic drug treatment for dementia: meta-analysis of randomized placebo-controlled trials. JAMA 294: 1934–1943

    Article  CAS  Google Scholar 

  3. Schneider LS et al. (2006) Efficacy and adverse effects of atypical antipsychotics for dementia: meta-analysis of randomized, placebo-controlled trials. Am J Geriatr Psychiatry 14: 191–210

    Article  Google Scholar 

  4. McShane R et al. (2006) Memantine for dementia. Cochrane Database of Systematic Reviews 2007, Issue 2. Art. No.: CD003154.pub5. DOI: 10.1002/14651858.CD003154.pub5

  5. Fossey J et al. (2006) Effect of enhanced psychosocial care on antipsychotic use in nursing home residents with severe dementia: cluster randomised trial. BMJ 332: 756–761

    Article  Google Scholar 

Download references

Acknowledgements

The synopsis was written by Martina Habeck, Associate Editor, Nature Clinical Practice.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Clive Ballard.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ballard, C., Fossey, J. & Sharp, S. Antipsychotics in patients with Alzheimer's disease—what is their clinical value?. Nat Rev Neurol 3, 248–249 (2007). https://doi.org/10.1038/ncpneuro0472

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncpneuro0472

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing